Xbrane Biopharma Ab operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Xbrane Biopharma Ab with three other
companies in this sector in Sweden:
Medivir AB
(2018
sales of 23.86 million Swedish Kronor [US$2.50 million]
of which 100%
was Pharmaceutical),
Sprint Bioscience AB
(17.94 million Swedish Kronor [US$1.88 million]
), and
Active Biotech AB
(20.05 million Swedish Kronor [US$2.10 million]
of which 80%
was Rental revenues).
Sales Analysis.
Xbrane Biopharma Ab reported sales of SEK 20.49 million (US$2.15 million)
for the
year ending
December of 2018.
This
represents
a
decrease of 1.4%
versus 2017, when the company's sales were SEK 20.77 million.